iSERA Lifesciences is currently trading at upper limit of Rs. 72.71, up by 1.42 points or 1.99% from its previous closing of Rs. 71.29 on the BSE.

The scrip opened at Rs. 72.71 and has touched a high and low of Rs. 72.71 and Rs. 72.71 respectively. So far 25 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 72.71 on 22-Apr-2026 and a 52 week low of Rs. 1.50 on 03-Jul-2025.

Last one week high and low of the scrip stood at Rs. 72.71 and Rs. 67.19 respectively. The current market cap of the company is Rs. 61.14 crore.

The promoters holding in the company stood at 58.63%, while Non-Institutions held 41.37% stake in the company.

iSERA Lifesciences has received approval from Board of Directors for acquisition of equity shares representing up to 100% of the paid-up equity share capital of iSERA Biological, an unlisted public company, comprising up to 1,61,82,800 equity shares of face value Rs 10 each, from the existing shareholders of iSERA Biological, for a total consideration of Rs 78,00,10,960. Upon completion of the said acquisition, iSERA Biological shall become a wholly owned subsidiary of iSERA Lifesciences.

iSERA Lifesciences (Formerly known as Covidh Technologies) is a technology services provider with an established footprint across diverse domains.